Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Differential expression and molecular characterisation of Lmo7, Myo1e, Sash1, and Mcoln2 genes in Btk-defective B-cells.

Lindvall JM, Blomberg KE, Wennborg A, Smith CI.

Cell Immunol. 2005 May;235(1):46-55. Epub 2005 Aug 30.

PMID:
16137664
2.

Gene expression profile of B cells from Xid mice and Btk knockout mice.

Lindvall JM, Blomberg KE, Berglöf A, Yang Q, Smith CI, Islam TC.

Eur J Immunol. 2004 Jul;34(7):1981-91.

3.

Posttranscriptional regulation of Bruton's tyrosine kinase expression in antigen receptor-stimulated splenic B cells.

Nisitani S, Satterthwaite AB, Akashi K, Weissman IL, Witte ON, Wahl MI.

Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2737-42. Erratum in: Proc Natl Acad Sci U S A 2000 May 9;97(10):5679.

4.

The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages.

de Weers M, Verschuren MC, Kraakman ME, Mensink RG, Schuurman RK, van Dongen JJ, Hendriks RW.

Eur J Immunol. 1993 Dec;23(12):3109-14.

PMID:
8258324
5.

B cell receptor directs the activation of NFAT and NF-kappaB via distinct molecular mechanisms.

Antony P, Petro JB, Carlesso G, Shinners NP, Lowe J, Khan WN.

Exp Cell Res. 2003 Nov 15;291(1):11-24.

PMID:
14597404
6.

Bruton's tyrosine kinase and SLP-65 regulate pre-B cell differentiation and the induction of Ig light chain gene rearrangement.

Kersseboom R, Ta VB, Zijlstra AJ, Middendorp S, Jumaa H, van Loo PF, Hendriks RW.

J Immunol. 2006 Apr 15;176(8):4543-52.

7.

Expression of Bruton's agammaglobulinemia tyrosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cells.

Smith CI, Baskin B, Humire-Greiff P, Zhou JN, Olsson PG, Maniar HS, Kjellén P, Lambris JD, Christensson B, Hammarström L, et al.

J Immunol. 1994 Jan 15;152(2):557-65.

PMID:
8283037
8.

A phosphorylation site in Bruton's tyrosine kinase selectively regulates B cell calcium signaling efficiency by altering phospholipase C-gamma activation.

Guo S, Ferl GZ, Deora R, Riedinger M, Yin S, Kerwin JL, Loo JA, Witte ON.

Proc Natl Acad Sci U S A. 2004 Sep 28;101(39):14180-5. Epub 2004 Sep 16.

9.

Defective Toll-like receptor 9-mediated cytokine production in B cells from Bruton's tyrosine kinase-deficient mice.

Hasan M, Lopez-Herrera G, Blomberg KE, Lindvall JM, Berglöf A, Smith CI, Vargas L.

Immunology. 2008 Feb;123(2):239-49. Epub 2007 Aug 28.

10.

An essential role for Bruton's [corrected] tyrosine kinase in the regulation of B-cell apoptosis.

Anderson JS, Teutsch M, Dong Z, Wortis HH.

Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):10966-71. Erratum in: proc Natl Acad Sci U S A 1996 Dec 24;93(26):15522.

11.

Defective expression of Bruton's tyrosine kinase in acute lymphoblastic leukemia.

Goodman PA, Wood CM, Vassilev AO, Mao C, Uckun FM.

Leuk Lymphoma. 2003 Jun;44(6):1011-8.

PMID:
12854903
12.

Lmo7 is an emerin-binding protein that regulates the transcription of emerin and many other muscle-relevant genes.

Holaska JM, Rais-Bahrami S, Wilson KL.

Hum Mol Genet. 2006 Dec 1;15(23):3459-72. Epub 2006 Oct 26.

PMID:
17067998
13.
14.

Expression of Bruton's tyrosine kinase protein within the B cell lineage.

Genevier HC, Hinshelwood S, Gaspar HB, Rigley KP, Brown D, Saeland S, Rousset F, Levinsky RJ, Callard RE, Kinnon C, et al.

Eur J Immunol. 1994 Dec;24(12):3100-5.

PMID:
7805739
16.

Function of Bruton's tyrosine kinase during B cell development is partially independent of its catalytic activity.

Middendorp S, Dingjan GM, Maas A, Dahlenborg K, Hendriks RW.

J Immunol. 2003 Dec 1;171(11):5988-96.

18.

Distinct gene expression signature in Btk-defective T1 B-cells.

Lindvall JM, Blomberg KE, Berglöf A, Smith CI.

Biochem Biophys Res Commun. 2006 Jul 28;346(2):461-9. Epub 2006 Jun 2.

PMID:
16764821
19.

Bruton's tyrosine kinase mediates NF-kappa B activation and B cell survival by B cell-activating factor receptor of the TNF-R family.

Shinners NP, Carlesso G, Castro I, Hoek KL, Corn RA, Woodland RT, Scott ML, Wang D, Khan WN.

J Immunol. 2007 Sep 15;179(6):3872-80. Erratum in: J Immunol. 2007 Nov 1;179(9):6369. Woodland, Robert L [corrected to Woodland, Robert T].

20.

Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA).

Zhu Q, Zhang M, Rawlings DJ, Vihinen M, Hagemann T, Saffran DC, Kwan SP, Nilsson L, Smith CI, Witte ON, Chen SH, Ochs HD.

J Exp Med. 1994 Aug 1;180(2):461-70.

Supplemental Content

Support Center